A single-dose study to define tiagabine pharmacokinetics in pediatric patients with complex partial seizures.
about
Tiagabine add-on for drug-resistant partial epilepsyTiagabine add-on for drug-resistant partial epilepsyAn Updated Overview on Therapeutic Drug Monitoring of Recent Antiepileptic DrugsTiagabine add-on for drug-resistant partial epilepsy.Tiagabine.The clinical pharmacokinetics of the new antiepileptic drugs.Therapeutic Drug Monitoring of the Newer Anti-Epilepsy MedicationsAnticonvulsants and breast feeding: a critical review.Treatment of epilepsy in the multiply handicapped.Clinical pharmacokinetics of new-generation antiepileptic drugs at the extremes of age: an update.Clinical pharmacokinetics of new-generation antiepileptic drugs at the extremes of age.Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed?Use of second-generation antiepileptic drugs in the pediatric population.Tiagabine (gabitril) experience in children.Pharmacokinetic study of levetiracetam in children.Pre- rather than co-application of vigabatrin increases the efficacy of tiagabine in hippocampal slices.Tiagabine: a novel antiepileptic drug.Update on the newer antiepileptic drugs in child neurology: advances in treatment of pediatric epilepsy.The role of tiagabine in the treatment of intractable epilepsy of childhood with multifocal independent spikes: a case report.
P2860
Q24197804-308AEC02-429E-4414-96B4-BF92C36A7209Q24200559-BD6904A4-90AB-4E1E-A2F2-5CB175551870Q28069989-307CA02E-21E2-4D3C-A714-3E06839BB8A6Q30838762-529CB1D4-4AFA-4AC4-B8A2-4642550A5E5AQ33756760-9AB0007E-DC92-4321-89C9-45364F604364Q33804499-B84ED39B-5591-4FC9-A24C-879DABB7B34FQ33996679-A997C38C-3E0A-4FF5-A83B-3D3892CC8B5EQ33999176-C3136E26-7442-48EC-8785-316BDEBB6FE4Q34099234-ABBC597B-3113-4D02-BBC8-F696AAE2DB96Q34342674-5C1533CB-1A89-4053-A202-90E1E21C874EQ36439208-0D4292FC-E9E9-45DB-9DDE-DEFEAF0A1696Q36627204-1559EC12-F65C-464F-B1BA-57137384B8ADQ37203259-DAC1E68D-01D3-4DC8-8129-3A9A40D632ACQ42657648-DFEFACDF-3AA0-4AD7-8C0F-B5BB1BA5B6D0Q42671555-EFEB96A0-8AEC-40DE-8818-4DB2A357F770Q44235086-A8BFF06A-B0E2-4DB6-A386-3A7D805F8811Q48344925-F6463C70-DB75-4536-9276-5D37B7C5021EQ51967935-A0975B75-1808-43D7-A7D5-B1B95B2FF678Q51972652-CC893245-5D4A-4984-9BDD-ED45864EE94A
P2860
A single-dose study to define tiagabine pharmacokinetics in pediatric patients with complex partial seizures.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
A single-dose study to define ...... with complex partial seizures.
@en
A single-dose study to define ...... with complex partial seizures.
@nl
type
label
A single-dose study to define ...... with complex partial seizures.
@en
A single-dose study to define ...... with complex partial seizures.
@nl
prefLabel
A single-dose study to define ...... with complex partial seizures.
@en
A single-dose study to define ...... with complex partial seizures.
@nl
P2093
P356
P1433
P1476
A single-dose study to define ...... with complex partial seizures.
@en
P2093
Boellner SW
Granneman GR
Guenther HJ
Gustavson LE
Sommerville KW
el-Shourbagy T
P304
P356
10.1212/WNL.48.4.1032
P407
P577
1997-04-01T00:00:00Z